TMO(Thermo Fisher Scientific Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $39.21B | $44.91B | $42.86B | $42.88B | $44.56B |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $10.03B | $8.39B | $6.86B | $7.34B | $7.75B |
| 净利润 | $7.73B | $6.96B | $6.00B | $6.33B | $6.70B |
| 经营现金流 | $9.31B | $9.15B | $8.41B | $8.67B | $7.82B |
| 自由现金流 | $6.79B | $6.91B | $6.93B | $7.27B | $6.29B |
| 摊薄每股收益 | $19.46 | $17.63 | $15.45 | $16.53 | $17.74 |